Bioanalysis of aplidine, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography after derivatization with trans-4′-hydrazino-2-stilbazole

Rolf W. Sparidans(Slotervaartziekenhuis), Jos H. Beijnen(The Netherlands Cancer Institute), R.E.C. Henrar(European Organisation for Research and Treatment of Cancer), Bastiaan Nuyen(Slotervaartziekenhuis), José Jimeno(European Organisation for Research and Treatment of Cancer), Kenneth L. Rinehart(University of Illinois Urbana-Champaign), J.Jantien Kettenes-van den Bosch(Utrecht University), Olaf van Tellingen(Dutch Cancer Society), Glynn Faircloth(PharmaMar (Spain)), Pablo Floriano(PharmaMar (Spain))
Journal of Chromatography B Biomedical Sciences and Applications
June 1, 1999
10.1016/s0378-4347(99)00118-8
Cited by 19

Related Papers

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.
|PubMed|2002|688